Suchergebnisse - "Reid, Tony"

PubPharm (45)

1

PREVLAR : Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy

enthalten in: International journal of radiation oncology, biology, physics | 2023

von Bonomi, M. | Blakaj, D. | Kabarriti, R. | +13

2

Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME)

enthalten in: Frontiers in immunology | 2023

von Reid, T. | Oronsky, B. | Caroen, S. | +4

3

Vascular priming with RRx-001 to increase the uptake and accumulation of temozolomide and irinotecan in orthotopically implanted gliomas

enthalten in: Journal of drug targeting | 2021

von Oronsky, B. | Reid, T. | Cabrales, P.

4

Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development

enthalten in: Journal of medicinal chemistry | 2021

von Oronsky, B. | Guo, X. | Wang, X. | +9

5

Desperate Times, Desperate Measures : The Case for RRx-001 in the Treatment of COVID-19

enthalten in: Seminars in oncology | 2020

von Oronsky, B. | Knox, S. | Cabrales, P. | +2

6

Pancreas Cancer-Associated Weight Loss

enthalten in: The oncologist | 2019

von Hendifar, A. | Petzel, M. | Zimmers, T. | +40

7

A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors

enthalten in: Investigational new drugs | 2017

von Kim, G. | Reid, T. | Shin, S. | +4

8

Turning on the Radio : Epigenetic Inhibitors as Potential Radiopriming Agents

enthalten in: Biomolecules | 2016

von Oronsky, B. | Scicinski, J. | Kim, M. | +9

9

Task Shifting the Management of Non-Communicable Diseases to Nurses in Kibera, Kenya : Does It Work?

enthalten in: PloS one | 2016

von Some, D. | Edwards, J. | Reid, T. | +9

10

Safety and activity of RRx-001 in patients with advanced cancer : a first-in-human, open-label, dose-escalation phase 1 study

enthalten in: The Lancet. Oncology | 2015

von Reid, T. | Oronsky, B. | Scicinski, J. | +17

CommentIn: Lancet Oncol. 2015 Sep;16(9):1013-5. - PMID 26296953

1
2
3
4
5
Nächster »
[5]